Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M304654200 on May 30, 2003 Originally published In Press as doi:10.1074/jbc.M304654200 on May 30, 2003 Originally published In Press as doi:10.1074/jbc.M304654200 on May 29, 2003

J. Biol. Chem., Vol. 278, Issue 33, 30614-30623, August 15, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/33/30614    most recent
M304654200v3
M304654200v2
M304654200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armoni, M.
Right arrow Articles by Karnieli, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armoni, M.
Right arrow Articles by Karnieli, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Peroxisome Proliferator-activated Receptor-{gamma} Represses GLUT4 Promoter Activity in Primary Adipocytes, and Rosiglitazone Alleviates This Effect*

Michal Armoni {ddagger} §, Natalia Kritz {ddagger}, Chava Harel {ddagger}, Fabiana Bar-Yoseph {ddagger}, Hui Chen ¶, Michael J. Quon ¶ and Eddy Karnieli {ddagger}

From the {ddagger}Institute of Endocrinology, Diabetes, and Metabolism, Rambam Medical Center and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel and the NCCAM, National Institutes of Health, Bethesda, Maryland 20892-1632

The synthetic thiazolidinedione ligands of peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}) improve insulin sensitivity in type II diabetes and induce GLUT4 mRNA expression in fat and muscle. However, the molecular mechanisms involved are still unclear. We studied the regulatory effects of PPAR{gamma} and its ligands on GLUT4 gene expression in primary rat adipocytes and CHO-K1 cells cotransfected with PPAR{gamma} and the GLUT4 promoter reporter. PPAR{gamma}1 and PPAR{gamma}2 repressed the activity of the GLUT4 promoter in a dose-dependent manner. Whereas this repression was augmented by the natural ligand 15{Delta}-prostaglandin J2, it was completely alleviated by rosiglitazone (Rg). Ligand binding-defective mutants PPAR{gamma}1-L468A/E471A and PPAR{gamma}2-L496A/E499A retained the repression effect, which was unaffected by Rg, whereas the PPAR{gamma}2-S112A mutant exhibited a 50% reduced capacity to repress GLUT4 promoter activity. The –66/+163 bp GLUT4 promoter region was sufficient to mediate PPAR{gamma} inhibitory effects. The PPAR{gamma}/retinoid X receptor-{alpha} heterodimer directly bound to this region, whereas binding was abolished in the presence of Rg. Thus, we show that PPAR{gamma} represses transcriptional activity of the GLUT4 promoter via direct and specific binding of PPAR{gamma}/retinoid X receptor-{alpha} to the GLUT4 promoter. This effect requires an intact Ser112 phosphorylation site on PPAR{gamma} and is completely alleviated by Rg, acting via its ligand-binding domain. These data suggest a novel mechanism by which Rg exerts its antidiabetic effects via detaching PPAR{gamma} from the GLUT4 gene promoter, thus leading to increased GLUT4 expression and enhanced insulin sensitivity.


Received for publication, May 5, 2003 , and in revised form, May 29, 2003.

* This work was supported in part by Grant 358/99-2 from the Israel Science Foundation of the Israel Academy of Science and Humanities and by grants from the General Apotropus Fund-Israel Ministry of Health and the L. R. Diamond Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Unit of Molecular Endocrinology, Inst. of Endocrinology, Diabetes, and Metabolism, Rambam Medical Center, Haifa 31096, Israel. Tel.: 972-4-854-3514; Fax: 972-4-854-2746; E-mail: amichal{at}tx.technion.ac.il.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. A. Lima, G. F. Anhe, G. Giannocco, M. T. Nunes, M. L. Correa-Giannella, and U. F. Machado
Contractile activity per se induces transcriptional activation of SLC2A4 gene in soleus muscle: involvement of MEF2D, HIF-1a, and TR{alpha} transcriptional factors
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E132 - E138.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Karnieli and M. Armoni
Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E38 - E45.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Armoni, C. Harel, S. Karni, H. Chen, F. Bar-Yoseph, M. R. Ver, M. J. Quon, and E. Karnieli
FOXO1 Represses Peroxisome Proliferator-activated Receptor-{gamma}1 and -{gamma}2 Gene Promoters in Primary Adipocytes: A NOVEL PARADIGM TO INCREASE INSULIN SENSITIVITY
J. Biol. Chem., July 21, 2006; 281(29): 19881 - 19891.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Armoni, C. Harel, F. Bar-Yoseph, S. Milo, and E. Karnieli
Free Fatty Acids Repress the GLUT4 Gene Expression in Cardiac Muscle via Novel Response Elements
J. Biol. Chem., October 14, 2005; 280(41): 34786 - 34795.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H.-P. Guan, T. Ishizuka, P. C. Chui, M. Lehrke, and M. A. Lazar
Corepressors selectively control the transcriptional activity of PPAR{gamma} in adipocytes
Genes & Dev., February 15, 2005; 19(4): 453 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Pawliczak, C. Logun, P. Madara, M. Lawrence, G. Woszczek, A. Ptasinska, M. L. Kowalski, T. Wu, and J. H. Shelhamer
Cytosolic Phospholipase A2 Group IV{alpha} but Not Secreted Phospholipase A2 Group IIA, V, or X Induces Interleukin-8 and Cyclooxygenase-2 Gene and Protein Expression through Peroxisome Proliferator-activated Receptors {gamma} 1 and 2 in Human Lung Cells
J. Biol. Chem., November 19, 2004; 279(47): 48550 - 48561.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Schwartzenberg-Bar-Yoseph, M. Armoni, and E. Karnieli
The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression
Cancer Res., April 1, 2004; 64(7): 2627 - 2633.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement